Literature DB >> 12925010

Ca2+-sensitive regulation of E-type Ca2+ channel activity depends on an arginine-rich region in the cytosolic II-III loop.

Jérôme Leroy1, Alexey Pereverzev, Rolf Vajna, Ning Qin, Gabriele Pfitzer, Jürgen Hescheler, Claire O Malécot, Toni Schneider, Udo Klöckner.   

Abstract

Ca2+-dependent regulation of L-type and P/Q-type Ca2+ channel activity is an important mechanism to control Ca2+ entry into excitable cells. Here we addressed the question whether the activity of E-type Ca2+ channels can also be controlled by Ca2+. Switching from Ba2+ to Ca2+ as charge carrier increased within 50 s, the density of currents observed in HEK-293 cells expressing a human Cav2.3d subunit and slowed down the inactivation kinetics. Furthermore, with Ca2+ as permeant ion, recovery from inactivation was accelerated, compared to the recovery process recorded under conditions where the accumulation of [Ca2+]i was prevented. In a Ba2+ containing bath solution the Ca2+-dependent changes of E-type channel activity could be induced by dialysing the cells with 1 micro m free [Ca2+]i suggesting that an elevation of [Ca2+]i is responsible for these effects. Deleting 19 amino acids in the intracellular II-III linker (exon 19) as part of an arginine-rich region, severely impairs the Ca2+ responsiveness of the expressed channels. Interestingly, deletion of an adjacent homologue arginine-rich region activates channel activity but now independently from [Ca2+]i. As a positive feedback-regulation of channel activity this novel activation mechanism might determine specific biological functions of E-type Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925010     DOI: 10.1046/j.1460-9568.2003.02819.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  9 in total

Review 1.  Neuronal calcium channels: splicing for optimal performance.

Authors:  Annette C Gray; Jesica Raingo; Diane Lipscombe
Journal:  Cell Calcium       Date:  2007-05-18       Impact factor: 6.817

2.  The N terminus of a schistosome beta subunit regulates inactivation and current density of a Cav2 channel.

Authors:  Vicenta Salvador-Recatalà; Robert M Greenberg
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

3.  Cumulative inactivation of N-type CaV2.2 calcium channels modified by alternative splicing.

Authors:  Christopher Thaler; Annette C Gray; Diane Lipscombe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-01       Impact factor: 11.205

4.  Atypical properties of a conventional calcium channel beta subunit from the platyhelminth Schistosoma mansoni.

Authors:  Vicenta Salvador-Recatalà; Toni Schneider; Robert M Greenberg
Journal:  BMC Physiol       Date:  2008-03-26

5.  Review: Cav2.3 R-type Voltage-Gated Ca2+ Channels - Functional Implications in Convulsive and Non-convulsive Seizure Activity.

Authors:  Carola Wormuth; Andreas Lundt; Christina Henseler; Ralf Müller; Karl Broich; Anna Papazoglou; Marco Weiergräber
Journal:  Open Neurol J       Date:  2016-09-30

Review 6.  Cav2.3 R-type calcium channels: from its discovery to pathogenic de novo CACNA1E variants: a historical perspective.

Authors:  T Schneider; F Neumaier; J Hescheler; S Alpdogan
Journal:  Pflugers Arch       Date:  2020-06-11       Impact factor: 3.657

7.  FMRP regulates presynaptic localization of neuronal voltage gated calcium channels.

Authors:  Laurent Ferron; Cesare G Novazzi; Kjara S Pilch; Cristian Moreno; Krishma Ramgoolam; Annette C Dolphin
Journal:  Neurobiol Dis       Date:  2020-01-25       Impact factor: 5.996

8.  How "Pharmacoresistant" is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?

Authors:  Toni Schneider; Maxine Dibué; Jürgen Hescheler
Journal:  Pharmaceuticals (Basel)       Date:  2013-05-27

Review 9.  In vitro and in vivo phosphorylation of the Cav2.3 voltage-gated R-type calcium channel.

Authors:  T Schneider; S Alpdogan; J Hescheler; F Neumaier
Journal:  Channels (Austin)       Date:  2018       Impact factor: 2.581

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.